Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enzastaurin shows potential in phase II follicular lymphoma trial

July 8, 2010

Phase I data reported on PCI-32765 in non-Hodgkin's lymphoma

July 8, 2010

Best response of stable disease seen in phase I BI-811283 trial in solid tumors

July 8, 2010

NIH awards grant to Dynavax to develop universal HPV vaccine

July 7, 2010

Roche submits T-DM1 BLA to FDA for advanced HER2-positive breast cancer

July 7, 2010

Ariad Pharmaceuticals reports new protein kinase inhibitors

July 7, 2010

CGI and Genentech discover new Bruton tyrosine kinase inhibitors

July 7, 2010

Safety and antitumor activity of BMS-754807 reported in phase I trial

July 7, 2010

Cell Therapeutics files updated Pediatric Investigation Plan for pixantrone to the EMA

July 6, 2010

ADVENTRX reports encouraging 9-month data from stability tests of Exelbine

July 6, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...